相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Mapping human microbiome drug metabolism by gut bacteria and their genes
Michael Zimmermann et al.
NATURE (2019)
Validation of a clinical pharmacogenetic model to predict methotrexate nonresponse in rheumatoid arthritis patients
Frank Eektimmerman et al.
PHARMACOGENOMICS (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Broad collateral damage of drugs against the gut microbiome
Peter Spanogiannopoulos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients
John C. Taylor et al.
PHARMACOGENOMICS JOURNAL (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients
Matthew K. Doherty et al.
MBIO (2018)
How to Determine the Role of the Microbiome in Drug Disposition
Jordan E. Bisanz et al.
DRUG METABOLISM AND DISPOSITION (2018)
Short- and long-term effects of oral vancomycin on the human intestinal microbiota
Sandrine Isaac et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
NMRProcFlow: a graphical and interactive tool dedicated to 1D spectra processing for NMR- based metabolomics
D. Jacob et al.
METABOLOMICS (2017)
Chemical transformation of xenobiotics by the human gut microbiota
Nitzan Koppel et al.
SCIENCE (2017)
Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
Qi Qiu et al.
SCIENTIFIC REPORTS (2017)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases
Ashwin N. Ananthakrishnan et al.
CELL HOST & MICROBE (2017)
The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis
XiaoBing Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
Peter Spanogiannopoulos et al.
NATURE REVIEWS MICROBIOLOGY (2016)
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS & RHEUMATOLOGY (2016)
The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment
Xuan Zhang et al.
NATURE MEDICINE (2015)
Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis
Raphael Sanches Peres et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Belimumab for Systemic Lupus Erythematosus: A Cochrane Systematic Review and MetaAnalysis
Jasvinder A. Singh et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease
Jose U. Scher et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Methotrexate for the treatment of rheumatoid arthritis in the biologic era: Still an anchor drug?
Ennio Giulio Favalli et al.
AUTOIMMUNITY REVIEWS (2014)
Use of Oral and Subcutaneous Methotrexate in Rheumatoid Arthritis Patients in the United States
Jeffrey R. Curtis et al.
ARTHRITIS CARE & RESEARCH (2014)
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
Jacqueline Detert et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Diversity, stability and resilience of the human gut microbiota
Catherine A. Lozupone et al.
NATURE (2012)
Markers of Treatment Response toMethotrexate in Rheumatoid Arthritis: Where Do We Stand?
Karina I. Halilova et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2012)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis
Tracey M. Farragher et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Methotrexate Polyglutamate Concentrations Are Not Associated With Disease Control in Rheumatoid Arthritis Patients Receiving Long-Term Methotrexate Therapy
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2010)
Feature Selection with the Boruta Package
Miron B. Kursa et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Measurement of Erythrocyte Methotrexate Polyglutamate Levels: Ready for Clinical Use in Rheumatoid Arthritis?
Maria I. Danila et al.
Current Rheumatology Reports (2010)
A core gut microbiome in obese and lean twins
Peter J. Turnbaugh et al.
NATURE (2009)
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
Paul Emery et al.
LANCET (2008)
A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis
Judith A. M. Wessels et al.
ARTHRITIS AND RHEUMATISM (2007)
Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis
Axel Finckh et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis
Thierry Dervieux et al.
ARTHRITIS AND RHEUMATISM (2006)
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis
T Dervieux et al.
ARTHRITIS AND RHEUMATISM (2004)
Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis
VPK Nell et al.
RHEUMATOLOGY (2004)
分享论文
